MetabolismNews.net

Metabolism Xagena

Search results for "Bone loss"

Researchers at Johns Hopkins have determined that for subjects aged 55 to 75 years, a moderate program of physical exercise generally maintains bone mass and, in some cases, offers modest improvements ...


Drugs that reverse and prevent bone loss due to osteoporosis also significantly ward off periodontal disease. Leena Bahl Palomo, at the Case Western Reserve University School of Dental Medicine, co ...


Twice-yearly subcutaneous injections of Denosumab ( 60 mg; Prolia ) increased bone mineral density ( BMD ) in the lumbar spine, total hip, distal 1/3 radius and total body compared to placebo at 24 mo ...


Researchers at the University of Bonn have identified a previously unknown regulatory mechanism in the process of bone loss. Their findings could open up new approaches to the treatment of osteoporo ...


Researchers at the Stanford University School of Medicine have found that a new osteoporosis drug, called Teriparatide ( Forteo ), is not cost-effective compared with the most commonly prescribed oste ...


Twice-yearly treatment with Denosumab ( Prolia ) has increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer.The report is published in ...


Patients who take glucocorticoid drugs ( such as Prednisolone or Prednisone ) to treat a variety of inflammatory/immune-mediated diseases ( such as rheumatoid arthritis or asthma ) can suffer side eff ...


La Food and Drug Administration ( FDA ) has approved a new indication for Prolia ( Denosumab ) as a treatment to increase bone mass in men with osteoporosis at high risk for fracture. Prolia, the firs ...


The results from a phase II trial for Odanacatib, a cathepsin K ( cat-K ) inhibitor in development for the treatment of osteoporosis in post-menopausal women, were presented at the 34th Annual Meeting ...